Sahajanand Medical Technologies opens Rs 475 crore IPO as medtech exports expand

Sahajanand Medical Technologies has launched its Rs 475.48 crore initial public offering for public bidding, marking another milestone for India's indigenous medical technology sector. Bidding for the equity issue, structured entirely as an offer for sale, opened on October 15 and runs through October 19.

Offer structure and key dates

The company set a price band of Rs 327 to Rs 344 per equity share, with a face value of Re 1 per share. Retail investors can participate with a minimum bid lot of 43 shares, requiring an upfront commitment of Rs 14,792 at the top end of the band. Share allotment is scheduled for finalisation on October 21, ahead of trading on both the BSE and the National Stock Exchange on October 23.

Growth in domestic manufacturing and exports

The listing demonstrates the strength of domestic capital markets and investor appetite for high-value Indian manufacturing. Founded in 2001, Sahajanand Medical Technologies designs and manufactures complex cardiovascular hardware, including drug-eluting coronary stents, transcatheter aortic valve implantation devices, and drug-coated balloons.

The firm's export capabilities expanded to cover 77 countries in the 2026 financial year, up from 65 countries in prior periods, showing the increasing global footprint of Indian health technology companies.

Motilal Oswal Investment Advisors, Avendus Capital, HSBC Securities and Capital Markets (India), and Nuvama Wealth Management are serving as book running lead managers for the issue, with MUFG Intime India acting as registrar.